Coliform Mastitis (E. coli, Klebsiella)

Coliform mastitis represents one of the most severe and potentially life-threatening forms of mammary gland infection affecting dairy cattle worldwide. This acute inflammatory condition is caused by gram-negative bacteria, primarily Escherichia coli and Klebsiella species, which originate from environmental sources rather than spreading from cow to cow. Unlike contagious mastitis pathogens that colonize the udder and spread during milking, coliform organisms are opportunistic invaders that typically cause rapid-onset, severe clinical disease when they enter the mammary gland through the teat canal.

The condition predominantly affects dairy cattle, with highest incidence occurring in high-producing cows during the periparturient period and early lactation when immune function is naturally suppressed. Coliform mastitis accounts for approximately twenty to forty percent of all clinical mastitis cases in well-managed dairy herds, with E. coli being the most frequently isolated pathogen followed by Klebsiella pneumoniae and Klebsiella oxytoca. The disease occurs sporadically in individual animals rather than in outbreak patterns, reflecting its environmental rather than contagious nature.

The economic and welfare impact of coliform mastitis is substantial and extends far beyond the immediate costs of treatment. Affected cows frequently experience significant milk production losses that may persist throughout the lactation, with some quarters becoming permanently non-functional. The systemic nature of severe cases often results in extended recovery periods, increased culling rates, and occasional mortality. Studies estimate that each case of severe coliform mastitis costs producers between five hundred and one thousand dollars when accounting for treatment expenses, discarded milk, production losses, veterinary fees, and potential premature culling.

Early detection and aggressive intervention are absolutely critical for successful outcomes in coliform mastitis cases. The rapid progression from initial infection to systemic toxemia can occur within hours, making prompt recognition of early clinical signs essential. While coliform mastitis was historically associated with high mortality rates, advances in supportive care protocols and improved understanding of endotoxin-mediated pathophysiology have significantly improved survival rates when treatment is initiated early. Modern management approaches focus on supportive therapy to combat the effects of endotoxemia rather than relying solely on antimicrobial treatment, as the bacteria themselves are often rapidly eliminated by the immune response.

The primary causative agents of coliform mastitis are gram-negative bacteria belonging to the family Enterobacteriaceae, with Escherichia coli being the most common pathogen isolated from clinical cases. Klebsiella species, particularly Klebsiella pneumoniae and Klebsiella oxytoca, represent the second most frequent cause and are often associated with more severe clinical outcomes and poorer response to treatment. Other coliform organisms including Enterobacter species and Citrobacter species may occasionally cause mastitis but are less commonly encountered. These bacteria are normal inhabitants of the bovine intestinal tract and are ubiquitous in the dairy environment, particularly in bedding materials, manure, soil, and contaminated water sources.

While coliform mastitis is not considered a hereditary condition, genetic factors influencing immune competence may affect individual susceptibility to infection and disease severity. Research has identified variations in genes controlling neutrophil function, cytokine production, and toll-like receptor expression that correlate with mastitis resistance or susceptibility. Some breeding programs now incorporate mastitis resistance traits, including somatic cell score, into selection indices. Daughters of bulls with superior mastitis resistance genetics tend to have lower rates of clinical mastitis including coliform infections, suggesting that while the infection itself is not inherited, the capacity to resist or respond to infection has genetic components.

Environmental and management factors play the predominant role in coliform mastitis epidemiology. Bacteria gain access to the mammary gland through the teat canal, with contamination occurring between milkings when teats contact contaminated bedding, flooring, or environmental surfaces. Organic bedding materials such as sawdust, recycled manure solids, and straw support higher bacterial populations than inorganic materials like sand. Poor stall maintenance, inadequate bedding replacement, overcrowding, and high environmental temperatures with humidity all increase bacterial exposure and mastitis risk. Milking hygiene practices including pre-milking teat preparation, post-milking teat disinfection, and milking equipment maintenance also influence transmission risk.

Several risk factors predispose individual cows to coliform mastitis development. The periparturient period represents the highest risk time, as immune function is naturally suppressed around calving due to hormonal changes and negative energy balance. High-producing cows experience greater immune suppression and have milk that supports more rapid bacterial growth. The dry period, particularly the early dry period before keratin plug formation and the colostrogenesis period before calving, presents vulnerability windows. Teat end condition, including hyperkeratosis and teat injuries, affects bacterial penetration. Previous mastitis episodes, concurrent diseases, poor body condition, and advanced age all increase susceptibility to new infections.

The pathophysiology of coliform mastitis involves rapid bacterial multiplication within the mammary gland followed by release of endotoxin (lipopolysaccharide) from bacterial cell walls. Unlike gram-positive mastitis pathogens that often establish chronic infections, coliforms typically trigger an intense acute inflammatory response that eliminates most bacteria within twenty-four to forty-eight hours. However, the endotoxin released during bacterial death is absorbed into the bloodstream and triggers systemic inflammatory response syndrome. This endotoxemia is responsible for the severe clinical signs including fever, depression, dehydration, and cardiovascular compromise that characterize toxic coliform mastitis. The severity of disease correlates more closely with the intensity of the inflammatory response and endotoxin absorption than with bacterial numbers in the gland.

Early warning signs of coliform mastitis may be subtle and easily overlooked, making vigilant observation essential for prompt detection. Initial changes often include mild depression, slightly reduced feed intake, and decreased milk production that may precede obvious udder abnormalities by several hours. Affected cows may show subtle changes in behavior such as reluctance to enter the milking parlor, restlessness, or positioning themselves away from herdmates. Milk appearance from the affected quarter may show early changes including wateriness, flakes, or slight discoloration before dramatic abnormalities develop. Recognizing these early indicators provides the best opportunity for successful intervention before systemic toxemia develops.

Clinical symptoms in cattle progress rapidly and dramatically in moderate to severe cases of coliform mastitis. The affected quarter typically becomes swollen, hot, and painful within hours of clinical onset, though the degree of visible swelling may be less pronounced than with some gram-positive infections. Milk from the infected quarter undergoes characteristic changes, becoming watery, serum-like, or bloody with a distinctive foul odor in some cases. Production from the affected quarter drops precipitously and may cease entirely. The quarter often feels firm or hard on palpation, and cows typically show marked pain responses when the udder is examined or during milking.

Behavioral changes accompany the physical symptoms and provide important diagnostic clues. Affected cows rapidly go off feed and stop ruminating, with complete anorexia common in severe cases. They may isolate themselves from the herd, stand with an arched back, show reluctance to move, and appear profoundly depressed or obtunded. Affected animals frequently lie down and may be reluctant to rise. Milk let-down is often poor due to pain and stress hormone release. In lactating beef cattle or less frequently observed dairy animals, behavioral changes may be the first signs noticed before udder abnormalities are detected.

Physical examination reveals systemic signs that distinguish toxic coliform mastitis from less severe forms of mammary infection. Fever is common early in the disease course, with rectal temperatures often exceeding 104 to 106 degrees Fahrenheit, though hypothermia may develop in advanced or terminal cases. Heart rate is elevated, often exceeding one hundred beats per minute, and heart sounds may be muffled. Respiratory rate increases, and mucous membranes may appear injected initially then become pale or muddy as shock develops. Skin tenting indicates dehydration, and extremities including ears and lower limbs may feel cold due to peripheral vasoconstriction.

Symptom progression in untreated or severe cases follows a predictable but rapid course. Within twelve to twenty-four hours of onset, profound dehydration develops due to fluid sequestration, reduced intake, and ongoing losses. Rumen stasis leads to bloating and further depression of appetite. Muscle weakness progresses to recumbency in severe cases, and cows may become unable to rise. Diarrhea is common and further contributes to fluid and electrolyte losses. The affected quarter may develop a cold, bluish discoloration indicating compromised blood supply and impending gangrene. Milk secretion ceases entirely, and the quarter may begin leaking serum.

Emergency symptoms requiring immediate veterinary intervention include complete anorexia and water refusal, recumbency or inability to rise, profoundly depressed mentation or stupor, cold extremities with pale or cyanotic mucous membranes, bloody or gangrenous appearance of the affected quarter, rapid deterioration despite initial treatment, and temperature below normal suggesting cardiovascular collapse. These signs indicate severe endotoxic shock with potential for rapid mortality. Cows presenting with these emergency symptoms require aggressive intravenous fluid therapy and intensive supportive care within hours to have any reasonable chance of survival.

Clinical examination forms the foundation of coliform mastitis diagnosis, with the combination of acute onset, severe systemic illness, and characteristic milk changes being highly suggestive of gram-negative infection. Veterinary examination should include thorough assessment of all four quarters, even when only one appears affected, as multiple quarter infections can occur. Physical examination parameters including temperature, heart rate, respiratory rate, hydration status, rumen motility, and mucous membrane color help assess disease severity and guide treatment intensity. The affected quarter is evaluated for heat, swelling, pain response, and milk character. California Mastitis Test performed on milk from all quarters helps identify subclinical involvement and establish baseline somatic cell levels.

Diagnostic testing provides definitive identification of the causative organism and guides treatment decisions. Milk samples should be collected aseptically from affected quarters before initiating antimicrobial therapy whenever possible. Standard aerobic culture on blood agar and MacConkey agar allows identification of gram-negative organisms within twenty-four to forty-eight hours. Klebsiella colonies typically appear mucoid on culture due to their capsule production. Antimicrobial susceptibility testing helps guide therapy selection, though initial treatment is usually initiated empirically before results are available. Rapid on-farm culture systems using selective media can provide preliminary gram-negative versus gram-positive differentiation within twenty-four hours. Polymerase chain reaction testing offers faster and more specific pathogen identification but is not yet widely available for routine clinical use.

Differential diagnosis for acute toxic mastitis includes other severe mammary infections and conditions causing similar systemic signs. Staphylococcus aureus can occasionally cause peracute gangrenous mastitis with severe systemic illness. Pseudomonas aeruginosa mastitis may present similarly and is often associated with contaminated water supplies or teat dip solutions. Mycoplasma mastitis, while typically less acute, should be considered in herds with unexplained mastitis outbreaks. Non-infectious conditions including udder edema, udder hematoma, and acute teat injuries may initially appear similar. Systemic diseases such as acute metritis, traumatic reticuloperitonitis, and grain overload can cause depression and fever that might be confused with mastitis if udder examination is not thorough.

Herd-level diagnostic evaluation becomes important when coliform mastitis incidence exceeds expected levels or when Klebsiella is identified. Environmental sampling of bedding materials can quantify bacterial loads and identify contamination sources. Bulk tank cultures provide herd-level prevalence information for contagious pathogens but are less useful for environmental organisms. Analysis of mastitis records including timing of cases relative to calving, affected quarters, and response to treatment helps identify risk factors and management deficiencies. Water source testing may be indicated when unusual organisms or outbreak patterns occur. Bedding bacteria counts exceeding one million colony forming units per gram indicate excessive contamination requiring management changes. Klebsiella isolation warrants investigation of organic bedding materials, particularly sawdust and recycled manure solids, which commonly harbor this organism.

Emergency treatment for severe coliform mastitis focuses on combating endotoxic shock and should be initiated immediately upon recognition of systemic illness. Aggressive intravenous fluid therapy represents the cornerstone of supportive care, with hypertonic saline followed by large volumes of isotonic fluids helping restore circulating volume and tissue perfusion. A typical protocol involves administration of two to four liters of hypertonic seven percent saline followed by ten to twenty liters or more of balanced electrolyte solution over the first several hours. Continued fluid support may be necessary for twenty-four to forty-eight hours in severe cases. Anti-inflammatory therapy using flunixin meglumine or other non-steroidal anti-inflammatory drugs helps counteract endotoxin effects and provides analgesia. Frequent milking or stripping of the affected quarter every two to four hours helps remove bacteria, toxins, and inflammatory mediators from the gland.

Medical management of coliform mastitis has evolved considerably as understanding of the disease pathophysiology has improved. Systemic antimicrobial therapy is commonly administered, though its necessity in mild to moderate cases is debated since most infections are rapidly cleared by the immune response. When antimicrobials are used, drugs with gram-negative spectrum including ceftiofur, fluoroquinolones where permitted, and aminoglycosides are appropriate choices. Intramammary antimicrobial therapy is generally considered less critical than systemic treatment and supportive care. Withdrawal times must be carefully observed for all antimicrobials used in food-producing animals, with extended withdrawals required for extra-label drug use. Veterinary oversight ensures appropriate drug selection and legal compliance with food safety regulations.

Surgical intervention is occasionally necessary in coliform mastitis cases that progress to gangrenous mastitis. Teat amputation may be performed to provide drainage when the quarter becomes necrotic, though this is a salvage procedure with guarded prognosis. Complete mastectomy is rarely performed in cattle but may be considered in valuable animals with localized gangrene. More commonly, surgical intervention involves debridement of necrotic tissue and establishment of drainage. These procedures require careful consideration of the cow's overall condition, prognosis, economic value, and welfare implications. Most gangrenous cases ultimately require culling once the acute crisis is managed.

Supportive care beyond fluid therapy includes several important components. Calcium supplementation helps maintain normal muscle function and supports immune response, particularly in periparturient cows prone to hypocalcemia. Oral or intravenous glucose or propylene glycol addresses the negative energy balance that develops with anorexia. Rumen transfaunation may benefit cows with prolonged anorexia and rumen stasis. Nursing care including deep bedding, shelter from temperature extremes, and assistance rising helps prevent secondary complications. Pain management through continued NSAID administration improves welfare and may enhance recovery. Appetite stimulants and palatable feeds encourage return to normal intake.

Herd treatment protocols for coliform mastitis emphasize early detection and rapid intervention rather than treatment of multiple animals simultaneously, given the sporadic nature of environmental infections. Standard operating procedures should define clinical signs requiring treatment, initial therapy protocols that can be initiated by trained farm personnel, and criteria for veterinary involvement. Treatment records must document all drugs administered, dosages, routes, and withdrawal dates. Protocols should differentiate between mild cases amenable to intramammary therapy alone, moderate cases requiring systemic antimicrobials and anti-inflammatories, and severe toxic cases demanding intensive supportive care.

Treatment decision factors in coliform mastitis cases include both medical and economic considerations. Severity of systemic illness, response to initial therapy, and presence of complications such as gangrene influence prognosis. Economic factors including the cow's production potential, breeding value, stage of lactation, and replacement costs affect treatment intensity decisions. Age and parity matter, as older cows generally have poorer prognosis. The quarter's production history and whether other quarters remain functional affect future productivity. In some cases, humane euthanasia or salvage slaughter after appropriate withdrawal periods may be more appropriate than prolonged treatment with poor prognosis. These decisions should involve veterinary input and consider both animal welfare and economic realities.

Recovery timeline for coliform mastitis varies considerably depending on disease severity and promptness of treatment initiation. Mild cases with minimal systemic involvement may show significant improvement within twenty-four to forty-eight hours, with return to normal appetite and attitude followed by gradual improvement in milk quality and quantity over five to seven days. Moderate cases typically require three to five days before systemic signs resolve, with udder recovery taking one to two weeks. Severely affected cows surviving the acute toxic phase may require weeks to months for full recovery, and some never return to previous production levels. The affected quarter frequently remains compromised throughout the lactation even when the cow recovers systemically.

Post-treatment care and monitoring continue well beyond resolution of acute clinical signs. Daily observation for recurrence of fever, depression, or udder abnormalities should continue for at least one week after apparent recovery. Milk from the affected quarter should be monitored for quality and tested to confirm clearance of infection before ending intramammary therapy if used. Somatic cell counts typically remain elevated for weeks to months following clinical resolution and should be monitored through regular testing. Gradual return to normal feeding and production should be allowed rather than immediate return to high-challenge diets. Follow-up veterinary examination helps assess quarter damage and long-term prognosis.

Prognosis factors influencing recovery include several cow-level and disease characteristics. Severity of initial systemic illness strongly predicts outcome, with cows presenting in severe endotoxic shock having guarded to poor prognosis even with aggressive treatment. Speed of treatment initiation dramatically affects survival, with each hour of delay reducing successful outcome probability. The causative organism matters, as Klebsiella infections generally carry worse prognosis than E. coli. Development of gangrene indicates grave prognosis for quarter survival and reduces overall cow survival. Age, concurrent diseases, and nutritional status influence the cow's capacity to mount effective immune response and recover from illness.

Return to production considerations require realistic assessment of quarter damage and overall cow productivity. The affected quarter may never return to pre-infection production levels, with studies showing average production losses of twenty to thirty percent in recovered quarters. Some quarters become non-functional or develop chronic subclinical mastitis. Overall lactation yield is reduced not only by the affected quarter but also by the systemic illness effects. Future mastitis risk may be elevated in previously infected quarters. Economic calculations should consider these production impacts when deciding whether to retain recovered cows. For valuable genetics, embryo transfer may allow recovery of genetic potential despite reduced production.

Vaccination protocols offer some protection against coliform mastitis, though available vaccines do not prevent infection entirely. The E. coli J5 bacterin is the most widely used coliform mastitis vaccine and has demonstrated efficacy in reducing clinical severity and mortality rather than preventing infection. Vaccination protocols typically involve a series of two to three doses during the dry period and early lactation, with annual boosters. Timing often targets administration at dry-off, three to four weeks before expected calving, and shortly after calving. While vaccination is not a substitute for good management, it provides meaningful additional protection and is particularly valuable in herds with significant coliform mastitis problems. Cost-benefit analysis generally favors vaccination in dairy operations with appreciable mastitis incidence.

Biosecurity measures for coliform mastitis focus on reducing environmental bacterial exposure rather than preventing cow-to-cow transmission. Clean, dry bedding is fundamental, with inorganic bedding materials such as sand being strongly preferred over organic materials for coliform control. When organic bedding is used, fresh material should be added frequently, and moisture management is critical. Stall maintenance including regular manure removal and adequate bedding depth reduces bacterial contact with teats. Alley cleaning and drainage prevent accumulation of contaminated slurry. Maternity pen hygiene is particularly important given the high susceptibility of periparturient cows. Pasture access may reduce coliform exposure compared to confinement housing in some systems.

Nutritional prevention supports immune function during the high-risk transition period. Adequate vitamin E and selenium nutrition enhances neutrophil function critical for clearing coliform infections. Avoiding severe negative energy balance through appropriate dry cow nutrition and fresh cow management supports immune competence. Careful transition diet management prevents metabolic disorders that increase mastitis susceptibility. Adequate dietary protein supports antibody production and tissue repair. Mycotoxin contamination of feeds may impair immune function and should be monitored. Vitamin A and beta-carotene supplementation may provide additional immune support during the dry and transition periods.

Management practices encompassing milking hygiene and environmental control form the primary defense against coliform mastitis. Pre-milking teat preparation including cleaning, drying, and predipping with effective germicide reduces bacterial contamination at milking. Post-milking teat disinfection with properly formulated barrier dip helps prevent new infections during the period before keratin plug reformation. Milking equipment maintenance including proper vacuum levels, pulsation, and liner condition prevents teat end damage that facilitates bacterial invasion. Dry cow management including teat sealants provides physical barrier protection during the vulnerable dry period. Stocking density management prevents overcrowding that increases bacterial exposure and stress.

Quarantine and testing protocols have limited applicability for coliform mastitis given its environmental rather than contagious nature. However, new animal introductions should include general health evaluation and udder examination. Cows with chronic mastitis of any cause represent infection reservoirs and potential shedders that contaminate the environment. Regular monitoring of bulk tank and individual cow somatic cell counts helps identify subclinical infections requiring attention. Culture of clinical cases provides valuable information about prevalent organisms and potential environmental sources. When Klebsiella is identified, investigation of bedding sources, particularly sawdust suppliers, may reveal contamination requiring sourcing changes. Water supplies should be evaluated if unusual gram-negative organisms are isolated.

Daily management and monitoring for coliform mastitis prevention requires systematic attention to environmental conditions, cow health, and early disease detection. Regular assessment of bedding cleanliness, moisture levels, and bacterial loads helps identify deteriorating conditions before mastitis increases. At each milking, personnel should evaluate udders and milk for abnormalities, reporting any changes for prompt evaluation. High-risk cows including fresh animals, previous mastitis cases, and those with elevated cell counts warrant enhanced observation. Body condition scoring and monitoring of feed intake help identify cows experiencing metabolic stress that increases mastitis susceptibility. Daily facility walks should assess stall conditions, water availability, ventilation, and overcrowding.

Housing and environmental management directly influence coliform mastitis incidence through effects on bacterial exposure and teat condition. Freestall design should provide adequate space, appropriate bedding depth, and proper positioning of neck rails and brisket boards to keep cows well-positioned on stalls. Sand bedding dramatically reduces coliform bacterial counts compared to organic materials and represents the gold standard for mastitis control. When organic bedding is necessary, frequent replacement, conditioning treatment, and moisture management help limit bacterial proliferation. Heat abatement through ventilation, soaking, and shade reduces heat stress that impairs immune function and increases environmental bacterial growth. Lighting programs supporting normal behavioral patterns may improve immune function.

Herd health programs integrate mastitis prevention into comprehensive health management. Vaccination schedules should include coliform vaccines timed appropriately around the dry period and freshening. Dry cow protocols encompassing nutrition, body condition management, appropriate dry period length, and teat sealant or dry cow therapy reduce new infections. Fresh cow monitoring programs identify early clinical and metabolic problems that increase mastitis risk. Regular veterinary herd health visits allow systematic review of mastitis trends, treatment protocols, and prevention strategies. Collaboration between producers, veterinarians, nutritionists, and milking equipment technicians addresses the multifactorial nature of mastitis control.

Record keeping and monitoring systems provide essential data for mastitis management decisions. Individual cow mastitis records should include date, affected quarter, clinical severity, treatment administered, culture results when available, and outcome. Monthly summaries of mastitis incidence, severity distribution, and pathogen prevalence allow trend monitoring. Somatic cell count data from DHIA testing identifies subclinical infections and monitors herd udder health status. Treatment records ensure withdrawal compliance and allow evaluation of treatment success rates. Benchmarking against industry standards and year-over-year comparisons guides continuous improvement. Computer-based herd management systems facilitate data collection, analysis, and reporting.

Economic considerations permeate all aspects of coliform mastitis management. Prevention investments including bedding choices, vaccination, and management time must be weighed against mastitis costs. Treatment decisions balance drug and veterinary costs against production losses and potential salvage value. Culling decisions require analysis of individual cow economics including production potential, breeding value, and replacement costs. Overall mastitis economic impact assessment helps justify prevention program investments. Cost tracking systems that capture direct costs, production losses, and premature culling provide data for economic analysis. Collaboration with extension specialists, veterinarians, and agricultural economists helps optimize decision making.

High-risk breeds and types for coliform mastitis are primarily defined by production characteristics rather than genetic susceptibility. Holstein cattle, representing the dominant dairy breed globally, account for the majority of coliform mastitis cases simply due to population size and intensive management. However, high-producing Holsteins also face genuinely elevated risk due to immune suppression associated with high milk production, larger udders more prone to environmental contamination, and intensive management systems. Jersey cattle may have somewhat lower clinical mastitis rates in some studies, potentially related to smaller udder size and lower production volume. Brown Swiss, Guernsey, and Ayrshire breeds show varying mastitis susceptibility patterns that are not consistent across studies.

Production type dramatically influences coliform mastitis risk, with dairy cattle facing far greater incidence than beef cattle. Within dairy operations, high-producing cows face greater risk than lower producers due to more severe negative energy balance and immune suppression during early lactation. First-lactation heifers often show lower coliform mastitis rates than multiparous cows, possibly due to better immune function and less teat end damage. Cows in early lactation, particularly the first two months after calving, experience peak coliform mastitis incidence. Conversely, cows in late lactation with lower production and positive energy balance show reduced susceptibility. The dry period presents distinct risk patterns with vulnerability at both ends of the dry period.

Genetic selection and testing offer opportunities for long-term improvement in mastitis resistance. Genomic selection now allows identification of animals carrying favorable alleles for mastitis resistance traits. Somatic cell score is a heritable trait that responds to selection, with daughters of low-SCS sires showing reduced clinical mastitis incidence. Some countries include clinical mastitis directly in genetic evaluations. Breeding values for udder conformation traits including udder depth, teat placement, and teat length influence environmental exposure and machine milkability. Progressive breeding programs balance production traits with health and fitness characteristics. While no breed or genetic line is immune to coliform mastitis, genetic progress can meaningfully reduce herd-level susceptibility over time.

Commonly co-occurring conditions with coliform mastitis reflect both shared risk factors and consequences of the severe systemic illness. Hypocalcemia and milk fever frequently accompany or precede coliform mastitis, as low calcium impairs immune function and increases susceptibility. Ketosis and fatty liver syndrome compromise immune response and often coexist with mastitis in transition cows. Displaced abomasum may follow the anorexia and digestive disturbance associated with severe mastitis. Metritis and retained placenta share the periparturient risk period and indicate compromised transition cow health. Laminitis may develop as a sequela to the endotoxemia and metabolic disturbance of severe coliform mastitis. Secondary infections may establish in cows weakened by mastitis illness.

Conditions with similar symptoms requiring differentiation from coliform mastitis include other causes of acute systemic illness with udder involvement. Staphylococcus aureus mastitis occasionally presents as peracute gangrenous disease resembling severe coliform mastitis. Pseudomonas mastitis may cause acute severe illness, particularly in outbreaks associated with contaminated water or teat dip. Mycoplasma mastitis, while typically less acute, can cause severe disease in naive herds. Non-mastitis conditions including acute metritis, peritonitis, and toxemia from other sources may present with similar systemic signs, making thorough udder examination essential. Traumatic injuries to the udder including hematomas and lacerations may cause acute swelling and pain.

Complications and sequelae of coliform mastitis extend beyond the acute illness period. Gangrenous mastitis represents the most severe local complication, with tissue death leading to sloughing and potential septicemia. Permanent quarter loss occurs frequently, with the affected gland becoming non-functional. Chronic subclinical mastitis may persist in quarters that appear to recover clinically. Teat damage from swelling and necrosis may affect future milking. Systemic complications include disseminated intravascular coagulation, multiple organ dysfunction, and death in severe cases. Recovered cows may show persistent elevations in somatic cell count and reduced production. Secondary bacterial infections may establish during the immunocompromised recovery period.